Absence of self-reported neuropsychiatric and somatic symptoms after Omicron variant SARS-CoV-2 breakthrough infections.
Long COVID
Omicron
SARS-CoV-2 breakthrough infection
neuropsychiatric deficits
Journal
Brain communications
ISSN: 2632-1297
Titre abrégé: Brain Commun
Pays: England
ID NLM: 101755125
Informations de publication
Date de publication:
2023
2023
Historique:
received:
15
07
2022
revised:
16
11
2022
accepted:
23
03
2023
medline:
12
4
2023
entrez:
11
4
2023
pubmed:
12
4
2023
Statut:
epublish
Résumé
Persistent somatic and neuropsychiatric symptoms have been frequently described in patients after infection with severe acute respiratory syndrome coronavirus 2 even after a benign clinical course of the acute infection during the early phases of the coronavirus severe acute respiratory syndrome coronavirus 2 pandemic and are part of Long COVID. The Omicron variant emerged in November 2021 and has rapidly become predominant due to its high infectivity and suboptimal vaccine cross-protection. The frequency of neuropsychiatric post-acute sequelae after infection with the severe acute respiratory syndrome coronavirus 2 Omicron and adequate vaccination status is not known. Here, we aimed to characterize post-acute symptoms in individuals with asymptomatic or mildly symptomatic breakthrough infection with severe acute respiratory syndrome coronavirus 2. These individuals had either proven infection with the Omicron variant (
Identifiants
pubmed: 37038497
doi: 10.1093/braincomms/fcad092
pii: fcad092
pmc: PMC10082557
doi:
Types de publication
Journal Article
Langues
eng
Pagination
fcad092Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain.
Déclaration de conflit d'intérêts
The authors declare no competing interests and no conflict of interest. MAF received honoraria for consultation and travel expenses from Biogen, Merck KGaA, Novartis and Roche unrelated to this work.
Références
J Pers Soc Psychol. 2003 Apr;84(4):822-48
pubmed: 12703651
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
JAMA Netw Open. 2021 Oct 1;4(10):e2128568
pubmed: 34643720
J Psychosom Res. 2003 Apr;54(4):345-52
pubmed: 12670612
Ann Intern Med. 2007 Mar 6;146(5):317-25
pubmed: 17339617
EClinicalMedicine. 2021 Aug;38:101019
pubmed: 34308300
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Nature. 2021 Jul;595(7866):283-288
pubmed: 34010947
JAMA Intern Med. 2022 Jan 1;182(1):19-25
pubmed: 34747982
PLoS One. 2020 Nov 9;15(11):e0240784
pubmed: 33166287
Nat Med. 2021 Apr;27(4):626-631
pubmed: 33692530
J Psychosom Res. 2005 Jan;58(1):29-33
pubmed: 15771867
Lancet Infect Dis. 2021 Nov;21(11):1485-1486
pubmed: 34506735
Cell. 2022 Jul 7;185(14):2452-2468.e16
pubmed: 35768006
PLoS One. 2021 May 21;16(5):e0251661
pubmed: 34019562
Psychosomatics. 2009 Nov-Dec;50(6):613-21
pubmed: 19996233
EClinicalMedicine. 2021 Sep;39:101044
pubmed: 34316551
JAMA Netw Open. 2022 Jun 1;5(6):e2215934
pubmed: 35671054
Nature. 2021 Jun;594(7862):259-264
pubmed: 33887749
Sci Immunol. 2022 Sep 16;7(75):eabq2427
pubmed: 35653438
J Transl Med. 2022 Mar 16;20(1):129
pubmed: 35296346
JAMA Intern Med. 2014 Mar;174(3):399-407
pubmed: 24276929
Lancet Psychiatry. 2020 Oct;7(10):875-882
pubmed: 32593341
Nat Med. 2022 Jul;28(7):1461-1467
pubmed: 35614233
BMJ. 2020 Dec 23;371:m4938
pubmed: 33361141
JAMA Netw Open. 2021 May 3;4(5):e2111417
pubmed: 34037731
Brain Commun. 2020 Nov 23;2(2):fcaa205
pubmed: 33376990
EBioMedicine. 2022 Jun;80:104042
pubmed: 35526306
Lancet Psychiatry. 2020 Jul;7(7):611-627
pubmed: 32437679
Lancet. 2022 Jun 18;399(10343):2263-2264
pubmed: 35717982
Cell. 2022 Mar 3;185(5):881-895.e20
pubmed: 35216672
Int J Hyg Environ Health. 2021 Sep;238:113851
pubmed: 34601375
Lancet Neurol. 2020 Nov;19(11):919-929
pubmed: 33031735
Int J Infect Dis. 2020 May;94:55-58
pubmed: 32251791
Nat Commun. 2022 Apr 1;13(1):1745
pubmed: 35365631
iScience. 2021 Jul 23;24(7):102752
pubmed: 34179733
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022 Mar;65(3):398
pubmed: 34529097
Stem Cell Reports. 2022 Feb 8;17(2):307-320
pubmed: 35063125
N Engl J Med. 2020 Sep 3;383(10):989-992
pubmed: 32530583
Nat Immunol. 2022 Feb;23(2):210-216
pubmed: 35027728
BMJ Open. 2022 Jan 21;12(1):e057596
pubmed: 35063961
Brain Behav Immun. 2022 Jul;103:154-162
pubmed: 35447302
N Engl J Med. 2022 Jul 7;387(1):86-88
pubmed: 35731894
Brain Behav Immun. 2020 Aug;88:71-74
pubmed: 32561222
Euro Surveill. 2020 Mar;25(9):
pubmed: 32156329
EBioMedicine. 2020 Aug;58:102925
pubmed: 32745993
J Clin Microbiol. 2020 Aug 24;58(9):
pubmed: 32636214
Occup Environ Med. 2003 Jun;60 Suppl 1:i10-5
pubmed: 12782741
BMJ. 2021 Jul 26;374:n1648
pubmed: 34312178
JAMA Netw Open. 2021 Feb 1;4(2):e210830
pubmed: 33606031
Nature. 2021 Jul;595(7868):565-571
pubmed: 34153974
N Engl J Med. 2020 May 14;382(20):e60
pubmed: 32343504
JAMA. 2022 May 10;327(18):1748
pubmed: 35536278
Eur Heart J. 2022 Mar 14;43(11):1124-1137
pubmed: 34999762
World Psychiatry. 2022 Feb;21(1):124-132
pubmed: 34612005
Arthritis Res Ther. 2019 Mar 25;21(1):80
pubmed: 30909957